⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NAGE News
Niagen Bioscience, Inc. Common Stock
THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point
globenewswire.com
LEXX
WST
NAGE
PM
Niagen Bioscience Expands HSA/FSA Access for Tru Niagen ®, the Leading NAD+ Supplement in the U.S.*
businesswire.com
NAGE
Niagen Bioscience Acquires Existing Core Nicotinamide Riboside (NR) Patent Portfolio from Queen’s University Belfast
businesswire.com
NAGE
Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID
businesswire.com
NAGE
Niagen Bioscience Announces $10 Million Share Repurchase Program
businesswire.com
NAGE
Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook
businesswire.com
NAGE